Relationship between serum 25-hydroxyvitamin D and inflammatory cytokines in paediatric sickle cell disease

被引:31
作者
Adegoke, Samuel Ademola [1 ,2 ]
Smith, Olufemi Samuel [3 ]
Adekile, Adekunle D. [4 ]
Figueiredo, Maria Stella [1 ]
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, Haematol & Blood Transfus Div, Sao Paulo, SP, Brazil
[2] Obafemi Awolowo Univ, Dept Paediat & Child Hlth, Ife, Nigeria
[3] Obafemi Awolowo Univ, Teaching Hosp, Dept Chem Pathol, Ife, Nigeria
[4] Kuwait Univ, Dept Paediat, Fac Med, Kuwait, Kuwait
关键词
Cytokines; Paediatric; Sickle cell disease; Supplementation; 25-Hydroxyvitamin D; PROINFLAMMATORY CYTOKINES; VASOOCCLUSIVE CRISIS; HEART-FAILURE; CHILDREN; STATE; PATHOPHYSIOLOGY; EXPRESSION; PROFILES; ANEMIA; TARGET;
D O I
10.1016/j.cyto.2017.03.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background. Alteration in the concentration of inflammatory cytokines may contribute to pathogenesis in sickle cell anaemia (SCA). Vitamin D may suppress pro-inflammatory cytokines and enhance anti-inflammatory cytokines. Objective: To compare steady state levels of pro-and anti-inflammatory cytokines of Nigerian SCA children with age-and sex-matched healthy controls, and determine the relationship with 25-hydroxyvitamin-D (25-OHD). Effects of three months of vitamin D supplementation on cytokines of SCA children with suboptimal 25-OHD were also evaluated. Methods: Serum 25-OHD, IL-113, 2, 6, 8, 11, 12, 13, 17, 18 of 95 SCA children and 75 matched controls were determined using HPLC. The 12 SCA children with suboptimal 25-OHD received 2000 IU of vitamin D daily for 3 months, and their post supplementation cytokines and 25-OHD levels were compared with the baseline values. Results: IL-2, 6, 8, 12, 17 and 18 were higher in SCA children than the controls (p <= 0.001), but no significant variation in IL-11 and 13 (p = 0.131 and 0.057 respectively). Patients with suboptimal serum 25-OHD had higher IL-6, 8 and 18 (p = 0.003, 0.010 and 0.002 respectively) and lower levels of IL-11 (p = 0.005). Significant positive treatment effects were observed: post-supplementation, serum 25-OHD increased by 23.3 ng/mL, p < 0.001; proinflammatory cytokines IL-2, 6, 8, 17 and 18 (p < 0.001) were reduced and anti-inflammatory cytokine IL-11 was increased, p < 0.001. Conclusions: Suboptimal 250HD is associated with enhanced levels of pro-inflammatory markers in children with SCA. Three months of daily vitamin D supplementation reversed the trend. Hence; Vitamin D supplementation may reduce the inflammatory milieu and serve as an anti-inflammatory agent in the management of SCA.
引用
收藏
页码:87 / 93
页数:7
相关论文
共 36 条
  • [21] Anti-inflammatory cytokines
    Opal, SM
    DePalo, VA
    [J]. CHEST, 2000, 117 (04) : 1162 - 1172
  • [22] Cytokine profile of sickle cell disease in Oman
    Pathare, A
    Kindi, SA
    Ainaqdy, AA
    Daar, S
    Knox-Macaulay, H
    Dennison, D
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77 (04) : 323 - 328
  • [23] Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients With Sickle Cell Disease
    Qari, M. H.
    Dier, U.
    Mousa, S. A.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2012, 18 (02) : 195 - 200
  • [24] Th1 and Th2 cytokine profiles in sickle cell disease
    Raghupathy, R
    Haider, MZ
    Azizieh, F
    Abdelsalam, R
    D'Souza, TM
    Adekile, AD
    [J]. ACTA HAEMATOLOGICA, 2000, 103 (04) : 197 - 202
  • [25] Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition
    Sarray, Sameh
    Saleh, Layal R.
    Saldanha, F. Lisa
    Al-Habboubi, Hebah H.
    Mandi, Najat
    Almawi, Wassim Y.
    [J]. CYTOKINE, 2015, 72 (01) : 43 - 47
  • [26] Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial
    Schleithoff, SS
    Zittermann, A
    Tenderich, G
    Berthold, HK
    Stehle, P
    Koerfer, R
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (04) : 754 - 759
  • [27] Silva R. R., 2014, CYTOKINE, V65, P143
  • [28] Pathophysiology of sickle cell disease: Role of cellular and genetic modifiers
    Steinberg, MH
    Rodgers, GP
    [J]. SEMINARS IN HEMATOLOGY, 2001, 38 (04) : 299 - 306
  • [29] Taylor SC, 1999, J NATL MED ASSOC, V91, P619
  • [30] Thassila Nogueira P., 2013, ADV BIOSCI BIOTECHNO, V4, P6, DOI DOI 10.4236/ABB.2013.47A1002